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polygenic risk for neuropsychiatric 
disease and vulnerability to 
abnormal deep grey matter 
development
Harriet Cullen1, Michelle L. Krishnan1,3, saskia selzam2, Gareth Ball1,4, Alessia Visconti5, 
Alka saxena6, serena J. Counsell1, Jo Hajnal1,7, Gerome Breen2,8, Robert plomin2 & 
A. David edwards  1
Neuropsychiatric disease has polygenic determinants but is often precipitated by environmental 
pressures, including adverse perinatal events. However, the way in which genetic vulnerability and 
early-life adversity interact remains obscure. We hypothesised that the extreme environmental stress 
of prematurity would promote neuroanatomic abnormality in individuals genetically vulnerable 
to psychiatric disorders. In 194 unrelated infants (104 males, 90 females), born before 33 weeks of 
gestation (mean gestational age 29.7 weeks), we combined Magnetic Resonance Imaging with a 
polygenic risk score (PRS) for five psychiatric pathologies to test the prediction that: deep grey matter 
abnormalities frequently seen in preterm infants are associated with increased polygenic risk for 
psychiatric illness. the variance explained by the pRs in the relative volumes of four deep grey matter 
structures (caudate nucleus, thalamus, subthalamic nucleus and lentiform nucleus) was estimated 
using linear regression both for the full, mixed ancestral, cohort and a subsample of european infants. 
Psychiatric PRS was negatively associated with lentiform volume in the full cohort (β = −0.24, 
p = 8 × 10−4) and a European subsample (β = −0.24, p = 8 × 10−3). Genetic variants associated with 
neuropsychiatric disease increase vulnerability to abnormal lentiform development after perinatal 
stress and are associated with neuroanatomic changes in the perinatal period.
Preterm birth accounts for around 11% of all births and is a leading cause of infant mortality and morbidity1. 
It is a profound early-life stressor that is strongly associated with cognitive impairment, cerebral palsy, autism 
spectrum disorders and psychiatric disease2–5. Preterm birth is associated with both cerebral grey and white mat-
ter abnormalities. Research over the last decade has shown that the basal ganglia and thalamus are particularly 
vulnerable6–10. Boardman et al.6 showed the most marked morphological alteration between term and preterm 
infants to be a volume reduction in the thalamus and lentiform nucleus, a result confirmed by Srinivasan et al.7. 
Furthermore, this endophenotype has been associated with poorer neurodevelopmental outcome and neurode-
velopmental disability11,12. We hypothesized that the neuroanatomical abnormality defined by these studies might 
be associated with vulnerability to the environmental stress of preterm birth and this vulnerability might be 
greater in individuals who are at increased genetic risk for psychiatric disorders.
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Neuroanatomical and functional outcomes vary significantly between individuals and are likely to be modu-
lated by the interaction of genetic and environmental factors13,14. Adverse psychiatric outcomes have moderate to 
high heritability15, as do many brain-imaging phenotypes16–18, even in early infancy19.
Recent research into the genetics of psychiatric disease has shown it to be polygenic: psychiatric disorders 
are influenced by many genetic variants each of which has an individually small effect20. As samples sizes have 
grown, genome wide association studies (GWAS) have become increasingly informative, allowing detection of 
small effects of single nucleotide polymorphisms (SNPs), although SNPs reaching the stringent statistical criteria 
for genome-wide significance (typically P < 5 × 10−8) are few and collectively explain only a small percentage of 
the genetic variance of the disorder in question21. However, it is now possible to generate individual-specific gen-
otypic scores to predict phenotypic variance. GWAS results can be used to construct a polygenic risk score (PRS), 
which is an aggregate of trait-related effect sizes of SNPs across the genome in independent samples22.
We reasoned that if genes associated with psychiatric disease increase vulnerability to environmental effects 
on brain development, individuals with a greater polygenic risk for psychiatric disease who are subjected to the 
extreme environmental stress of preterm birth would be more likely to develop adverse consequences. Here, we 
exploit the power of previous large genome-wide studies measuring the polygenic risk for five different psychiat-
ric disorders23, combining this with a large set of Magnetic Resonance Imaging (MRI) data in preterm infants to 
test the prediction that: the characteristic abnormalities seen in the basal ganglia and thalamus of preterm infants 
are associated with a greater polygenic risk for psychiatric illness.
Results
Polygenic risk scores were computed at five different P-value thresholds (PT) for our sample of 194 preterm 
infants from summary statistics from the meta-analysis of genome-wide SNP data for five psychiatric disorders 
from the Cross-Disorder Group of the Psychiatric Genomics Consortium23. These were compared with structural 
MRI brain measures of four deep grey matter volumes for our cohort of preterm infants. Sample characteristics 
are given in Table 1.
The psychiatric PRS predicted subthalamic and lentiform nucleus volumes in preterm infants in both the full 
mixed-ancestral cohort and the sub-sample of European infants. The subthalamic and lentiform nuclei are shown 
in Fig. 1. For the full, mixed-ancestry cohort, the psychiatric PRS was negatively associated with lentiform nuclear 
volume (β = −0.24, p = 8 × 10−4, R2 = 0.057, (pT = 0.1)); the PRS also showed a modest negative association with 
subthalamic nuclear volume (β = −0.18, p = 0.01, R2 = 0.032, (pT = 0.05)) which did not survive multiple testing 
correction (Table 2 and Fig. 2a and b). In the sub-sample of European infants, the psychiatric PRS was nega-
tively associated with lentiform nuclear volume (β = −0.24, p = 8 × 10−3, R2 = 0.056, (pT = 0.1)) and subthalamic 
nuclear volume (β = −0.26, p = 3 × 10−3, R2 = 0.069, (pT = 0.05)) (Table 3 and Fig. 2c and d). For all associations 
with a p value < 0.05, the direction of the association was negative, that is, larger psychiatric genetic risk scores 
were associated with smaller deep grey matter volume. No association was found between the PRS and caudate 
or thalamic volume for either the full mixed-ancestral sample or the sub-sample of European infants (Tables 2 
and 3). We note that these results remain robust if we correct the deep grey matter volumes for a more extended 
list of covariates that includes postmenstrual age at scan, gender and birth weight in addition to gestational age 
at birth and brain volume.
As an additional check, we looked for a possible relationship between our psychiatric PRS and gestational age 
at birth, no statistically significant relationship was found at any of the five P-value cut-offs.
Discussion
We found evidence of an association between polygenic risk for psychiatric pathology and reduced lentiform 
volume in preterm infants. At its most predictive, in the full mixed-ancestry cohort, the psychiatric PRS explained 
approximately 6% of the variance in the lentiform nucleus volume. This is a comparatively large effect when com-
pared with other work looking at psychiatric genetic risk and brain volume24,25.
We also found evidence for an association between our psychiatric PRS and reduced subthalamic vol-
ume in our European subsample however this result did not survive multiple-testing correction in our full 
mixed-ancestral cohort. Given this discrepancy, and the comparatively small volume of this region, it remains 
difficult to draw conclusions about the subthalamic nuclear result.
We found no statistically significant association between polygenic risk for psychiatric pathology and the 
volume of the thalamus or caudate nucleus. We were surprised not to find an association with the thalamus which 
has been consistently shown to be a vulnerable region following preterm birth10. Finally, results from an explora-
tory analysis using developmental outcome data suggest that the psychiatric PRS may be functionally significant 
as there was a modest negative association with expressive language, although this did not survive multiple testing 
correction.
Ancestry
Number of 
Subjects
Mean Gestational 
Age (weeks)
Mean Postmenstrual 
Age at Scan (weeks)
Mean Intracranial 
Volume (ml)
European 122 29.7 ± 0.2 42.3 ± 0.2 569.1 ± 5.8
Asian 48 29.6 ± 0.3 42.7 ± 0.3 557.1 ± 11.0
African 24 29.3 ± 0.6 43.4 ± 0.6 585.9 ± 16.0
Combined Sample 194 29.7 ± 0.2 42.6 ± 0.2 568.2 ± 4.9
Table 1. Summary statistics for three different ancestral cohorts.
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Figure 1. Subthalamic nucleus (blue) and Lentiform nucleus (red) within glass brain (top right and top left). 
Lentiform nucleus (bottom left) and subthalamic nucleus (bottom right) overlayed on 40-week neonatal 
template (axial cut).
Psychiatric genetic risk 
scores: SNPs with P-values < 
Caudate Nucleus 
Volume
Thalamic 
Volume
Subthalamic 
Nucleus Volume
Lentiform 
Nucleus Volume
0.5
R2 0.007009 0.000452 0.001693 0.01871
β −0.08 0.02 −0.04 −0.14
P-value 0.25 0.77 0.57 0.06
0.1
R2 0.01342 0.004909 0.02266 0.0567
β −0.12 −0.07 −0.15 −0.24
P-value 0.11 0.33 0.04 0.0008*
0.05
R2 0.01417 0.004607 0.03233 0.04602
β −0.12 −0.07 −0.18 −0.21
P-value 0.10 0.34 0.01 0.0027*
0.01
R2 0.005814 0.001811 0.02966 0.02327
β −0.08 −0.04 −0.17 −0.15
P-value 0.29 0.56 0.02 0.03
0.001
R2 0.0106 0.000523 0.004517 0.005528
β −0.10 −0.02 −0.06 −0.07
P-value 0.15 0.75 0.35 0.30
Table 2. Effect size and significance of correlations between psychiatric PRS and deep grey matter volumes for 
the full mixed-ancestral cohort. Standardised beta co-efficients and raw P-values are quoted. Raw P-values < 0.05 
are shown in bold. Results surviving multiple-correction testing (p < 0.0083) are indicated with an asterisk (*).
www.nature.com/scientificreports/
4Scientific RepoRts |          (2019) 9:1976  | https://doi.org/10.1038/s41598-019-38957-1
Preterm infants have high levels of mental health problems and sub-diagnostic psychiatric symptomatologies, 
notably bipolar disorder, ADHD and ASD5,26; they also show characteristic abnormal deep grey matter develop-
ment6,7 which is associated with adverse neurocognitive outcome11,27. This led us to hypothesise that common 
genetic risk variants which increase the risk of psychiatric pathology might also increase vulnerability to aberrant 
development of the basal ganglia and thalamus in individuals subjected to the unusual environmental stresses 
associated with preterm birth. This hypothesis may well be correct. However, we must also consider an alternative 
explanation: that genetic variants which increase the risk of psychiatric pathology are more ubiquitously associ-
ated with abnormal lentiform development and that this association is independent of the environmental precip-
itants associated with prematurity and would be similarly observed in a cohort of term-born infants or adults. In 
future work, we will seek to address this question using a cohort of both term and preterm infants.
We employed summary statistics from the work of Smoller et al.23 using results from their overall analysis 
combining five psychiatric disorders: autism spectrum disorder (ASD), attention deficit-hyperactivity disor-
der (ADHD), bipolar disorder, major depressive disorder, and schizophrenia. The empirical evidence of shared 
genetic aetiology for psychiatric disorders is strong. Lee et al.28 showed a strong genetic correlation between 
schizophrenia and bipolar disorder (0.68 ± 0.04 s.e.), and moderate between schizophrenia and major depressive 
disorder (0.43 ± 0.06 s.e.), bipolar disorder and major depressive disorder (0.47 ± 0.06 s.e.), and ADHD and major 
depressive disorder (0.32 ± 0.07 s.e.). The risk attributable to prematurity is high for all psychiatric disease, and 
also for sub-threshold generalised psychiatric symptomatology5,26. This commonalty in both symptomatology 
and genetic predisposition supports the use of a combined PRS in this study.
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Figure 2. Proportion of variance explained in the subthalamic nucleus and lentiform nucleus volumes by the 
psychiatric PRS at five different P-value thresholds. Plots indicate the variance explained with estimated 95% 
confidence interval. The x-axis displays the five different upper thresholds of P-values for inclusion in the PRS. 
Results significant after multiple testing correction are indicated with an asterisk (*). (a) Subthalamic nucleus, 
full mixed-ancestral cohort, (b) Lentiform nucleus, full mixed-ancestral cohort, (c) Subthalamic nucleus, 
European sub-sample, (d) Lentiform nucleus, European sub-sample.
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A number of studies have explored links between brain structure and genetic risk for psychiatric disorders in 
the adult population25,29,30. Terwisscha Van Scheltinga et al.29 found polygenic risk for schizophrenia was signifi-
cantly associated with total brain volume. Other authors25 compared subcortical brain volume measures and PRS 
for schizophrenia and bipolar disorder in a sample of healthy adults; they found that most subcortical structures 
showed no association with a schizophrenia PRS with the exception of the globus pallidus and amygdala.
Xia et al.24 looked at genetic factors influencing global grey and white matter and intracranial volume in 
infants. They explored a possible association between genetic risk for both schizophrenia and ASD and global 
brain tissue volumes and found no association. They also integrated their GWAS results for global brain volumes 
with those for both adults and adolescents and found minimal overlap between common variants impacting brain 
volumes at different ages.
The most recent and largest adult study undertaken by Reus et al.30 looked at the impact of polygenic risk of 
major depressive disorder, schizophrenia, and bipolar disorder on subcortical brain volume and white matter 
microstructure. They found no statistically significant associations between either subcortical volumes or white 
matter microstructure and psychiatric polygenic risk, although they note a modest negative association between 
thalamic volume and the polygenic risk for schizophrenia. Franke et al.31 used a schizophrenia PRS and linkage 
disequilibrium (LD) score regression to test for shared genetic architecture between subcortical brain volume and 
schizophrenia and failed to find any overlap.
These large recent studies in adults have failed to show a robust association between deep grey matter volume 
and genetic psychiatric risk30,31. This makes our second explanation, that genetic variants associated with psychi-
atric risk are more generally associated with abnormal lentiform development, independent of environmental 
pressures, less likely. However, associations between brain volume and psychiatric risk might be more difficult 
to detect in older cohorts, or in cohorts where the environmental stressor is less extreme than preterm birth. 
Brain volumes in older individuals have been subject to variable environmental exposures for a far greater time 
than neonatal brains. Environmental effects, which include the influence of psychotropic medication32 may make 
genetic influences on brain structure more difficult to detect. It may be that the trajectory of growth of these struc-
tures is such that genetic overlap with psychiatric pathology is most easily detected early in life.
Studying preterm infants allows us to take a novel approach to the question of how genes that predispose to 
psychiatric disorders affect the brain at a neuroanatomical level. There is likely a strong interplay between envi-
ronment and genetic determinants in psychiatric disease and preterm delivery is a major environmental stressor. 
Imaging-genomics studies of preterm infants might therefore uncover effects of risk genes on brain structure that 
have been hard to detect in adult and term-born infant studies.
This study used an imaging endophenotype extracted from a large imaging dataset which was homogeneous 
in terms of MRI acquisition protocol, data pre-processing, analysis and quality control. One challenge of this 
dataset was its ancestral diversity. The discovery GWAS sample used to derive the PRS was of European ances-
try whereas our full cohort included infants of European, African and Asian origin. Excluding non-European 
infants would have significantly reduced our sample size and it is also important to generate growing amounts of 
evidence across a variety of common ancestral populations. We therefore undertook our analysis both in the full 
mixed-ancestral sample and performed an additional sensitivity analysis in the sub-sample of European babies. 
The general stability of results across the two cohorts is reassuring.
In summary, our study reports an association between volume of the lentiform nucleus in preterm infants and 
genetic risk for psychiatric pathology. Further annotation of the shared genetic architecture and its associated 
biological pathways may shed light on potential therapeutic strategies.
Psychiatric genetic risk scores: 
SNPs with P-values <
Caudate Nucleus 
Volume
Thalamic 
Volume
Subthalamic 
Nucleus Volume
Lentiform 
Nucleus Volume
0.5
R2 0.0114 8.451e-07 0.01263 0.02699
β −0.11 −0.001 −0.11 −0.16
P-value 0.24 0.99 0.22 0.07
0.1
R2 0.01247 0.01219 0.0669 0.05627
β −0.11 −0.11 −0.26 −0.24
P-value 0.22 0.23 0.004* 0.008*
0.05
R2 0.005469 0.003615 0.06896 0.04785
β −0.07 −0.06 −0.26 −0.22
P-value 0.42 0.51 0.003* 0.015
0.01
R2 0.01572 0.004908 0.05949 0.02919
β −0.13 −0.07 −0.24 −0.17
P-value 0.17 0.44 0.007* 0.06
0.001
R2 0.005688 8.784e-05 0.007118 0.005267
β −0.07 −0.01 −0.08 −0.07
P-value 0.41 0.92 0.36 0.43
Table 3. Effect size and significance of correlations between psychiatric PRS and deep grey matter volumes 
for the European cohort. Standardised beta coefficients and raw P-values are quoted. Raw P-values < 0.05 are 
shown in bold. Results surviving multiple-correction testing (p < 0.0083) are indicated with *.
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Methods and Materials
subjects. Preterm infants were recruited as part of the EPRIME (Evaluation of Magnetic Resonance (MR) 
Imaging to Predict Neurodevelopmental Impairment in Preterm Infants) study and were imaged at term equiva-
lent age. The EPRIME study was conducted according to the principles of the Declaration of Helsinki, and ethical 
approval was obtained from the UK National Research Ethics Service. Written parental informed consent was 
obtained for all subjects.
Imaging. MRI acquisition. MRI was performed on a Philips 3-Tesla system (Philips Medical Systems, Best, 
The Netherlands) within the Neonatal Intensive Care Unit using an 8-channel phased array head coil.
T1-weighted MRI was acquired using: repetition time (TR): 17 ms; echo time (TE): 4.6 ms; flip angle 13°; 
slice thickness: 0.8 mm; field of view: 210 mm; matrix: 256 × 256 (voxel size: 0.82 × 0.82 × 0.8 mm). T2-weighted 
fast-spin echo MRI was acquired using: TR: 14730 ms; TE: 160 ms; flip angle 90°; field-of-view: 220 mm; matrix: 
256 × 256 (voxel size: 0.86 × 0.86 × 2 mm) with 1 mm overlap.
Pulse oximetry, temperature and heart rate were monitored throughout and ear protection was used for each 
infant (President Putty, Coltene Whaledent, Mahwah, NJ; MiniMuffs, Natus Medical Inc, San Carlos, CA).
Image processing. T1-weighted images were brain-extracted with co-registered T2 brain masks (FSL’s BET; FSL 
5.0.8, http://fsl.fmrib.ox.ac.uk/fsl) and corrected for bias field inhomogeneities33. Each subjects’ T1-weighted 
image was aligned to a 40-week neonatal template34 using nonlinear registration35. Voxelwise maps of volume 
change induced by the transformation were characterized by the determinant of the Jacobian operator, referred 
to here as the Jacobian map. These maps include a global scaling factor, so Jacobian values reflect tissue vol-
ume differences due to both local deformation and global head size. T1-derived Jacobian maps were iteratively 
smoothed to a FWHM of 8 mm (AFNI’s 3dBlurToFWHM; http://afni.nimh.nih.gov/afni). Each map was then 
log-transformed so that values greater than zero represent local areal expansion in the subject relative to the target 
and values less than zero represent areal contraction.
Brain Endophenotype. The Jacobian maps were used to estimate the volume of regions of interest in the deep 
grey matter. Volume estimates for the bilateral volumes of the thalamus, subthalamic nucleus, caudate nucleus 
and lentiform nucleus (putamen and globus pallidus) were extracted by computing the mean log(Jacobian) within 
each region-specific mask. Masks were defined using a neonatal atlas36 aligned to a 40-week template.
Genotyping and quality control. 348 saliva samples were collected using Oragene DNA OG-250 kits 
(DNAGenotek Inc., Kanata, Canada) and genotyped on Illumina HumanOmniExpress-24 v1.1 arrays (Illumina, 
San Diego, CA, USA). Individuals with genotyping completeness <95% were excluded (29 individuals removed). 
SNPs with a minor allele frequency <0.01 (24546 SNPs), a missing genotype rate <99% (14672 SNPs) and devi-
ations from Hardy–Weinberg equilibrium, P < 1 × 10−7 (2307 SNPs) were removed. Where pairs with high levels 
of relatedness existed (pi-hat > 0.3) only one member of each pair was retained (44 individuals removed). This 
resulted in a sample of 275 individuals with high-quality genetic data (635266 SNPs). All quality control steps 
were carried out using PLINK 1.937 (Software: https://www.cog-genomics.org/plink/1.9/).
Population Stratification and Sample Selection. After pruning to remove markers in high linkage 
disequilibrium (r2 > 0.1, 72900 SNPs retained) we performed a Principal Component Analysis using PLINK 1.938. 
Inspection of the first two principal components in combination with reported ethnicity was used to define three 
ancestral populations: European, Asian and African (Supplementary Figure S1). Outliers from these three ances-
tral populations were excluded (35 individual removed). These three populations formed the cohorts for ongoing 
analysis (240 individuals).
Only those individuals with high quality MRI T1 data were retained (214 of the 240). Infants with major 
focal lesions such as periventricular leukomalacia, hemorrhagic parenchymal infarction and other ischaemic 
or haemorrhagic lesions were excluded from the analysis (20 infants). Supplementary Table S2 (Supplementary 
Information) gives further details of the focal brain lesions of the infants excluded. Our final sample comprised 
of 194 unrelated preterm infants (104 males, 90 females), mean gestational age 29.7 weeks, mean postmenstrual 
age at scan 42.6 weeks, including 122 individuals in the European cohort, 48 in the Asian cohort and 24 in the 
African cohort (Table 1).
polygenic scoring. We computed polygenic risk scores (PRS) for the 194 unrelated individuals using odds 
ratios and P-values from summary statistics obtained by the primary GWAS analysis from the Cross-Disorder 
Group of the Psychiatric Genomics Consortium23. This analysis combined the effects of five psychiatric diseases 
(autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, 
and schizophrenia) in 33332 cases and 27888 controls of European ancestry. The authors used a meta-analytic 
approach that applied a weighted Z-score with weights indicating the sample-size of the disease specific studies. 
The greatest power was therefore for SNPs that have an effect in multiple disorders.
PRS were generated in PRSice39. Initially the three ancestral sub-samples were considered independently. 
Quality-controlled SNPs were pruned for linkage disequilibrium based on P-value informed clumping using 
a r2 = 0.1 cut-off within a 250-kb window to create a SNP-set in linkage equilibrium for each of our ancestral 
cohorts. The MHC region was not removed in computation of the PRS, removal does not materially affect the 
results. PRS were computed at five different P-value thresholds (PT) in the discovery GWAS summary statistics: 
0.001, 0.01, 0.05, 0.1, 0.5. Scores were computed using genotyped SNPs in our target dataset. P-value thresholds 
and the number of SNPs contributing to the PRS for each of the three ancestral subsamples at each threshold are 
summarized in Supplementary Table S1.
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To control for population stratification, we regressed the PRS on the first 10 principal components of our 
ancestry matrix and used the residuals in all subsequent analysis. Details of the effect of this regression on the 
PRS distributions for our three ancestral cohorts are outlined in the supplementary information: Supplementary 
Methods and Supplementary Figures S2 and S3.
statistical Analysis. Bilateral deep grey matter brain volumes for the thalamus, subthalamic nucleus, cau-
date nucleus and lentiform nucleus (globus pallidus and putamen) were corrected for intracranial volume and 
gestational age at birth. Corrected volumes were then regressed on the ancestry-corrected PRS generated at five 
different P-value thresholds using simple linear regression in R. The variance explained by the PRS was obtained 
by squaring the regression coefficient.
Our full sample includes infants from three different ancestral cohorts: European, Asian and African. In con-
trast, the GWAS meta-analysis results23 used to compute the PRS were compiled using subjects of European 
ancestry only. We have therefore conducted an additional sensitivity analysis using a sub-sample of our cohort 
comprising only the European infants.
Preterm birth is known to be associated with an increased risk of psychiatric disease. We therefore checked 
for a possible association between the psychiatric PRS and degree of prematurity (gestational age at birth). We 
additionally undertook two exploratory analyses. We looked for a possible relationship between psychiatric PRS 
and developmental outcome and psychiatric PRS and intracranial volume (Supplementary Methods and Results).
Results quoted in Tables 2 and 3 are raw P-values. We have additionally computed a multiple-comparison 
P-value threshold. Since both the deep grey matter volumes and the five polygenic risk score thresholds are 
highly correlated we have used the method proposed by40 to compute the effective number of independent 
tests performed (Meff). This accounts for the correlation structure between measures and calculates the Meff 
based on the observed eigenvalue variance using the matSpD interface (https://gump.qimr.edu.au/general/
daleN/matSpD/). This calculation was performed for both the deep grey matter volumes (Meff_dgm) and the 
differently-thresholded polygenic scores (Meff_prs). The P-value for significance was determined as 0.05 divided 
by the product of Meff_dgm and Meff_prs. The four deep grey matter volumes resulted in two independent tests and 
the five differently-thresholded polygenic scores three independent tests, giving a multiple-comparison corrected 
P-value threshold of p < 0.008333. Results that survive the multiple-comparison correction in Tables 2 and 3 are 
indicated with an asterisk (*).
Data Availability
Data are available from the authors upon request, subject to approval of future uses by the National Research Eth-
ics Service. The study was approved by the UK National Research Ethics Service, and written parental informed 
consent was obtained for all subjects.
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